{"transactions":[{"id":1015827,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-21T00:00:02.000Z","date":"2025-10-17","kind":"sale","planned":false,"acquired":false,"shares":45513,"price":1.76,"value":80102.88,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1518893,"source":{"system":"sec-edgar","filing":"0001231919-25-000335","document":"form4-10202025_111053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000335/form4-10202025_111053.xml","form_type":"4"}},{"id":1015826,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-21T00:00:02.000Z","date":"2025-10-16","kind":"sale","planned":false,"acquired":false,"shares":85798,"price":1.72,"value":147572.56,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.795 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1564406,"source":{"system":"sec-edgar","filing":"0001231919-25-000335","document":"form4-10202025_111053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000335/form4-10202025_111053.xml","form_type":"4"}},{"id":1018412,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-16T00:07:14.000Z","date":"2025-10-15","kind":"sale","planned":false,"acquired":false,"shares":17960,"price":1.65,"value":29634.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.685 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1650204,"source":{"system":"sec-edgar","filing":"0001231919-25-000323","document":"form4-10162025_121006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000323/form4-10162025_121006.xml","form_type":"4"}},{"id":1018411,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-16T00:07:14.000Z","date":"2025-10-14","kind":"sale","planned":false,"acquired":false,"shares":28495,"price":1.65,"value":47016.75,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1668164,"source":{"system":"sec-edgar","filing":"0001231919-25-000323","document":"form4-10162025_121006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000323/form4-10162025_121006.xml","form_type":"4"}},{"id":1018410,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-16T00:07:14.000Z","date":"2025-10-13","kind":"sale","planned":false,"acquired":false,"shares":107361,"price":1.7,"value":182513.7,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1696659,"source":{"system":"sec-edgar","filing":"0001231919-25-000323","document":"form4-10162025_121006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000323/form4-10162025_121006.xml","form_type":"4"}},{"id":1020226,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-10T21:58:02.000Z","date":"2025-10-10","kind":"sale","planned":false,"acquired":false,"shares":2390,"price":1.77,"value":4230.3,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1804020,"source":{"system":"sec-edgar","filing":"0001231919-25-000308","document":"form4-10102025_091053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000308/form4-10102025_091053.xml","form_type":"4"}},{"id":1020225,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-10T21:58:02.000Z","date":"2025-10-09","kind":"sale","planned":false,"acquired":false,"shares":3979,"price":1.81,"value":7201.99,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1806410,"source":{"system":"sec-edgar","filing":"0001231919-25-000308","document":"form4-10102025_091053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000308/form4-10102025_091053.xml","form_type":"4"}},{"id":1020224,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-10T21:58:02.000Z","date":"2025-10-08","kind":"sale","planned":false,"acquired":false,"shares":7507,"price":1.77,"value":13287.39,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.74 to $1.805 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1810389,"source":{"system":"sec-edgar","filing":"0001231919-25-000308","document":"form4-10102025_091053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000308/form4-10102025_091053.xml","form_type":"4"}},{"id":1022148,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-07T22:14:58.000Z","date":"2025-10-07","kind":"sale","planned":false,"acquired":false,"shares":2100,"price":1.79,"value":3759.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.74 to $1.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1817896,"source":{"system":"sec-edgar","filing":"0001231919-25-000292","document":"form4-10072025_101049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000292/form4-10072025_101049.xml","form_type":"4"}},{"id":1022147,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-07T22:14:58.000Z","date":"2025-10-06","kind":"sale","planned":false,"acquired":false,"shares":17500,"price":1.78,"value":31150.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.7879 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1819996,"source":{"system":"sec-edgar","filing":"0001231919-25-000292","document":"form4-10072025_101049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000292/form4-10072025_101049.xml","form_type":"4"}},{"id":1022146,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-07T22:14:58.000Z","date":"2025-10-03","kind":"sale","planned":false,"acquired":false,"shares":600,"price":1.76,"value":1056.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.79 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1837496,"source":{"system":"sec-edgar","filing":"0001231919-25-000292","document":"form4-10072025_101049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000292/form4-10072025_101049.xml","form_type":"4"}},{"id":1027131,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-03T00:51:46.000Z","date":"2025-10-02","kind":"sale","planned":false,"acquired":false,"shares":600,"price":1.73,"value":1038.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.74 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1838096,"source":{"system":"sec-edgar","filing":"0001231919-25-000278","document":"form4-10032025_121037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000278/form4-10032025_121037.xml","form_type":"4"}},{"id":1027130,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-03T00:51:46.000Z","date":"2025-10-01","kind":"sale","planned":false,"acquired":false,"shares":2601,"price":1.8,"value":4681.8,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.785 to $1.81 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1838696,"source":{"system":"sec-edgar","filing":"0001231919-25-000278","document":"form4-10032025_121037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000278/form4-10032025_121037.xml","form_type":"4"}},{"id":1027129,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-03T00:51:46.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":4464,"price":1.81,"value":8079.84,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.80 to $1.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1841297,"source":{"system":"sec-edgar","filing":"0001231919-25-000278","document":"form4-10032025_121037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000278/form4-10032025_121037.xml","form_type":"4"}},{"id":1031165,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-30T00:06:37.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":500,"price":1.75,"value":875.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.76 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1845761,"source":{"system":"sec-edgar","filing":"0001231919-25-000258","document":"form4-09302025_120929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000258/form4-09302025_120929.xml","form_type":"4"}},{"id":1031164,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-30T00:06:37.000Z","date":"2025-09-26","kind":"sale","planned":false,"acquired":false,"shares":600,"price":1.68,"value":1008.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 to $1.73 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1846261,"source":{"system":"sec-edgar","filing":"0001231919-25-000258","document":"form4-09302025_120929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000258/form4-09302025_120929.xml","form_type":"4"}},{"id":1031163,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-30T00:06:37.000Z","date":"2025-09-25","kind":"sale","planned":false,"acquired":false,"shares":700,"price":1.66,"value":1162.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.64 to $1.67 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1846861,"source":{"system":"sec-edgar","filing":"0001231919-25-000258","document":"form4-09302025_120929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000258/form4-09302025_120929.xml","form_type":"4"}},{"id":1033011,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-24T22:49:10.000Z","date":"2025-09-24","kind":"sale","planned":false,"acquired":false,"shares":2256,"price":1.68,"value":3790.08,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.67 to $1.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1847561,"source":{"system":"sec-edgar","filing":"0001231919-25-000244","document":"form4-09242025_100902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000244/form4-09242025_100902.xml","form_type":"4"}},{"id":1033010,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-24T22:49:10.000Z","date":"2025-09-23","kind":"sale","planned":false,"acquired":false,"shares":4106,"price":1.72,"value":7062.32,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 to $1.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1849817,"source":{"system":"sec-edgar","filing":"0001231919-25-000244","document":"form4-09242025_100902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000244/form4-09242025_100902.xml","form_type":"4"}},{"id":1033009,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-24T22:49:10.000Z","date":"2025-09-22","kind":"sale","planned":false,"acquired":false,"shares":5410,"price":1.83,"value":9900.3,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1853923,"source":{"system":"sec-edgar","filing":"0001231919-25-000244","document":"form4-09242025_100902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000244/form4-09242025_100902.xml","form_type":"4"}},{"id":1035524,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-19T22:03:12.000Z","date":"2025-09-19","kind":"sale","planned":false,"acquired":false,"shares":3656,"price":1.79,"value":6544.24,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1859333,"source":{"system":"sec-edgar","filing":"0001231919-25-000221","document":"form4-09192025_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000221/form4-09192025_100903.xml","form_type":"4"}},{"id":1035523,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-19T22:03:12.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":5307,"price":1.74,"value":9234.18,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1862989,"source":{"system":"sec-edgar","filing":"0001231919-25-000221","document":"form4-09192025_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000221/form4-09192025_100903.xml","form_type":"4"}},{"id":1035522,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-19T22:03:12.000Z","date":"2025-09-17","kind":"sale","planned":false,"acquired":false,"shares":2304,"price":1.83,"value":4216.32,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.80 to $1.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1868296,"source":{"system":"sec-edgar","filing":"0001231919-25-000221","document":"form4-09192025_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000221/form4-09192025_100903.xml","form_type":"4"}},{"id":1039294,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-16T23:45:49.000Z","date":"2025-09-16","kind":"sale","planned":false,"acquired":false,"shares":840,"price":1.88,"value":1579.2,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.86 to $1.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1870600,"source":{"system":"sec-edgar","filing":"0001736814-25-000007","document":"form4-09162025_110941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000173681425000007/form4-09162025_110941.xml","form_type":"4"}},{"id":1039293,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-16T23:45:49.000Z","date":"2025-09-15","kind":"sale","planned":false,"acquired":false,"shares":2570,"price":1.84,"value":4728.8,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.77 to $1.87 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1871440,"source":{"system":"sec-edgar","filing":"0001736814-25-000007","document":"form4-09162025_110941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000173681425000007/form4-09162025_110941.xml","form_type":"4"}},{"id":1039292,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-16T23:45:49.000Z","date":"2025-09-12","kind":"sale","planned":false,"acquired":false,"shares":700,"price":1.85,"value":1295.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.83 to $1.87 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1874010,"source":{"system":"sec-edgar","filing":"0001736814-25-000007","document":"form4-09162025_110941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000173681425000007/form4-09162025_110941.xml","form_type":"4"}},{"id":1042793,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-11T23:43:40.000Z","date":"2025-09-11","kind":"sale","planned":false,"acquired":false,"shares":3820,"price":1.9,"value":7258.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.87 to $1.94 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1874710,"source":{"system":"sec-edgar","filing":"0001415889-25-024317","document":"form4-09112025_110935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925024317/form4-09112025_110935.xml","form_type":"4"}},{"id":1042792,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-11T23:43:40.000Z","date":"2025-09-10","kind":"sale","planned":false,"acquired":false,"shares":8176,"price":1.93,"value":15779.68,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.90 to $2.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1878530,"source":{"system":"sec-edgar","filing":"0001415889-25-024317","document":"form4-09112025_110935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925024317/form4-09112025_110935.xml","form_type":"4"}},{"id":1042791,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-11T23:43:40.000Z","date":"2025-09-09","kind":"sale","planned":false,"acquired":false,"shares":9050,"price":1.97,"value":17828.5,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.90 to $2.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1886706,"source":{"system":"sec-edgar","filing":"0001415889-25-024317","document":"form4-09112025_110935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925024317/form4-09112025_110935.xml","form_type":"4"}},{"id":1045794,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-08T22:55:36.000Z","date":"2025-09-08","kind":"sale","planned":false,"acquired":false,"shares":7090,"price":1.93,"value":13683.7,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1895756,"source":{"system":"sec-edgar","filing":"0001415889-25-023907","document":"form4-09082025_100931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023907/form4-09082025_100931.xml","form_type":"4"}},{"id":1045793,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-08T22:55:36.000Z","date":"2025-09-05","kind":"sale","planned":false,"acquired":false,"shares":1106,"price":1.86,"value":2057.16,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.82 to $1.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1902846,"source":{"system":"sec-edgar","filing":"0001415889-25-023907","document":"form4-09082025_100931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023907/form4-09082025_100931.xml","form_type":"4"}},{"id":1045792,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-08T22:55:36.000Z","date":"2025-09-04","kind":"sale","planned":false,"acquired":false,"shares":803,"price":1.82,"value":1461.46,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1903952,"source":{"system":"sec-edgar","filing":"0001415889-25-023907","document":"form4-09082025_100931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023907/form4-09082025_100931.xml","form_type":"4"}},{"id":1049541,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-03T23:57:06.000Z","date":"2025-09-03","kind":"sale","planned":false,"acquired":false,"shares":1270,"price":1.81,"value":2298.7,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1904755,"source":{"system":"sec-edgar","filing":"0001415889-25-023607","document":"form4-09032025_110901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023607/form4-09032025_110901.xml","form_type":"4"}},{"id":1049540,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-03T23:57:06.000Z","date":"2025-09-02","kind":"sale","planned":false,"acquired":false,"shares":2800,"price":1.78,"value":4984.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.67 to $1.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1906025,"source":{"system":"sec-edgar","filing":"0001415889-25-023607","document":"form4-09032025_110901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023607/form4-09032025_110901.xml","form_type":"4"}},{"id":1049539,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-03T23:57:06.000Z","date":"2025-08-29","kind":"sale","planned":false,"acquired":false,"shares":800,"price":1.74,"value":1392.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1908825,"source":{"system":"sec-edgar","filing":"0001415889-25-023607","document":"form4-09032025_110901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023607/form4-09032025_110901.xml","form_type":"4"}},{"id":1053551,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-29T00:39:13.000Z","date":"2025-08-28","kind":"sale","planned":false,"acquired":false,"shares":809,"price":1.81,"value":1464.29,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.82 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1909625,"source":{"system":"sec-edgar","filing":"0001415889-25-023258","document":"form4-08292025_120807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023258/form4-08292025_120807.xml","form_type":"4"}},{"id":1053550,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-29T00:39:13.000Z","date":"2025-08-27","kind":"sale","planned":false,"acquired":false,"shares":1300,"price":1.78,"value":2314.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.82 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1910434,"source":{"system":"sec-edgar","filing":"0001415889-25-023258","document":"form4-08292025_120807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023258/form4-08292025_120807.xml","form_type":"4"}},{"id":1053549,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-29T00:39:13.000Z","date":"2025-08-26","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":1.79,"value":3580.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.76 to $1.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1911734,"source":{"system":"sec-edgar","filing":"0001415889-25-023258","document":"form4-08292025_120807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023258/form4-08292025_120807.xml","form_type":"4"}},{"id":1056798,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-25T23:46:54.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":300,"price":1.77,"value":531.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.78 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1913734,"source":{"system":"sec-edgar","filing":"0001415889-25-022967","document":"form4-08252025_110849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022967/form4-08252025_110849.xml","form_type":"4"}},{"id":1056797,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-25T23:46:54.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":2376,"price":1.75,"value":4158.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.77 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1914034,"source":{"system":"sec-edgar","filing":"0001415889-25-022967","document":"form4-08252025_110849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022967/form4-08252025_110849.xml","form_type":"4"}},{"id":1056796,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-25T23:46:54.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":3034,"price":1.79,"value":5430.86,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.74 to $1.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1916410,"source":{"system":"sec-edgar","filing":"0001415889-25-022967","document":"form4-08252025_110849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022967/form4-08252025_110849.xml","form_type":"4"}},{"id":1060206,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-20T22:35:28.000Z","date":"2025-08-20","kind":"sale","planned":false,"acquired":false,"shares":3456,"price":1.74,"value":6013.44,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.76 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1919444,"source":{"system":"sec-edgar","filing":"0001415889-25-022532","document":"form4-08202025_100823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022532/form4-08202025_100823.xml","form_type":"4"}},{"id":1060205,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-20T22:35:28.000Z","date":"2025-08-19","kind":"sale","planned":false,"acquired":false,"shares":3604,"price":1.77,"value":6379.08,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1922900,"source":{"system":"sec-edgar","filing":"0001415889-25-022532","document":"form4-08202025_100823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022532/form4-08202025_100823.xml","form_type":"4"}},{"id":1060204,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-20T22:35:28.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":47668,"price":2.03,"value":96766.04,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.85 to $2.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1926504,"source":{"system":"sec-edgar","filing":"0001415889-25-022532","document":"form4-08202025_100823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022532/form4-08202025_100823.xml","form_type":"4"}},{"id":1065270,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-15T23:11:59.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":2900,"price":2,"value":5800.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1974172,"source":{"system":"sec-edgar","filing":"0001415889-25-022119","document":"form4-08152025_110853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022119/form4-08152025_110853.xml","form_type":"4"}},{"id":1065269,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-15T23:11:59.000Z","date":"2025-08-14","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":2,"value":4000.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares vat each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1977072,"source":{"system":"sec-edgar","filing":"0001415889-25-022119","document":"form4-08152025_110853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022119/form4-08152025_110853.xml","form_type":"4"}},{"id":1070145,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-08-04","kind":"sale","planned":false,"acquired":false,"shares":2196,"price":2.18,"value":4787.28,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":891734,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070144,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-18","kind":"sale","planned":false,"acquired":false,"shares":900,"price":2.2,"value":1980.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":893930,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070143,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-17","kind":"sale","planned":false,"acquired":false,"shares":20572,"price":2.19,"value":45052.68,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":894830,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070142,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-16","kind":"sale","planned":false,"acquired":false,"shares":5396,"price":2.24,"value":12087.04,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":915402,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070141,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-15","kind":"sale","planned":false,"acquired":false,"shares":2152,"price":2.28,"value":4906.56,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":920798,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070140,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-14","kind":"sale","planned":false,"acquired":false,"shares":801,"price":2.29,"value":1834.29,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":922950,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070139,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-11","kind":"sale","planned":false,"acquired":false,"shares":246,"price":2.29,"value":563.34,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":923751,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070138,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-10","kind":"sale","planned":false,"acquired":false,"shares":768,"price":2.28,"value":1751.04,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":923997,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070137,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":252,"price":2.27,"value":572.04,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":924765,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070136,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-08","kind":"sale","planned":false,"acquired":false,"shares":9059,"price":2.29,"value":20745.11,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":925017,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070135,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-02","kind":"sale","planned":false,"acquired":false,"shares":324,"price":2.42,"value":784.08,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":934076,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070134,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-01","kind":"sale","planned":false,"acquired":false,"shares":600,"price":2.43,"value":1458.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":934400,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070133,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-23","kind":"sale","planned":false,"acquired":false,"shares":1700,"price":3.09,"value":5253.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $3.06 to $3.19 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund II, L.P. (\"Fund II\"). Decheng Capital Management II (Cayman), LLC (\"GP II\") is the general partner of Fund II. Dr. Cui is the manager of GP II. Each of Fund II, GP II and Dr. Cui may be deemed to beneficially own the securities held by Fund II. Each of GP II and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1617409,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070132,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-20","kind":"sale","planned":false,"acquired":false,"shares":225217,"price":3.16,"value":711685.72,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $3.05 to $3.27 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund II, L.P. (\"Fund II\"). Decheng Capital Management II (Cayman), LLC (\"GP II\") is the general partner of Fund II. Dr. Cui is the manager of GP II. Each of Fund II, GP II and Dr. Cui may be deemed to beneficially own the securities held by Fund II. Each of GP II and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1619109,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070131,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-20","kind":"sale","planned":false,"acquired":false,"shares":60000,"price":3.11,"value":186600.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":935000,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070130,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-18","kind":"sale","planned":false,"acquired":false,"shares":59253,"price":3.17,"value":187832.01,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $3.10 to $3.34 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund II, L.P. (\"Fund II\"). Decheng Capital Management II (Cayman), LLC (\"GP II\") is the general partner of Fund II. Dr. Cui is the manager of GP II. Each of Fund II, GP II and Dr. Cui may be deemed to beneficially own the securities held by Fund II. Each of GP II and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1844326,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070129,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-17","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":3.23,"value":16150.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":995000,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1508933,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each option to purchase shares of Company Common Stock (a Company Option) that was then outstanding but not then vested or exercisable became immediately vested and exercisable in full. At the Effective Time, each Company Option that was then outstanding was automatically cancelled and, if such Company Option had a per share exercise price less than the Merger Consideration, the holder thereof became entitled to receive a cash payment, without interest thereon and subject to any applicable tax withholding, equal to the product obtained by multiplying (i) the total number of shares of Company Common Stock underlying such Company Option by (ii) the excess of the Merger Consideration over the exercise price per share such Company Option."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"(Continued from Footnote 7)  Any Company Option that had an exercise price per share that was equal to or exceeded the Merger Consideration was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"1/12th of the shares subject to the option become vested and exercisable on February 2, 2024 and 1/12 of the shares subject to the option shall vest monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":19,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1508932,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each option to purchase shares of Company Common Stock (a Company Option) that was then outstanding but not then vested or exercisable became immediately vested and exercisable in full. At the Effective Time, each Company Option that was then outstanding was automatically cancelled and, if such Company Option had a per share exercise price less than the Merger Consideration, the holder thereof became entitled to receive a cash payment, without interest thereon and subject to any applicable tax withholding, equal to the product obtained by multiplying (i) the total number of shares of Company Common Stock underlying such Company Option by (ii) the excess of the Merger Consideration over the exercise price per share such Company Option."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"(Continued from Footnote 7)  Any Company Option that had an exercise price per share that was equal to or exceeded the Merger Consideration was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option to purchase shares of Company Common Stock (the Company Option) is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":7.43,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1508931,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each option to purchase shares of Company Common Stock (a Company Option) that was then outstanding but not then vested or exercisable became immediately vested and exercisable in full. At the Effective Time, each Company Option that was then outstanding was automatically cancelled and, if such Company Option had a per share exercise price less than the Merger Consideration, the holder thereof became entitled to receive a cash payment, without interest thereon and subject to any applicable tax withholding, equal to the product obtained by multiplying (i) the total number of shares of Company Common Stock underlying such Company Option by (ii) the excess of the Merger Consideration over the exercise price per share such Company Option."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"(Continued from Footnote 7)  Any Company Option that had an exercise price per share that was equal to or exceeded the Merger Consideration was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option to purchase shares of Company Common Stock (the Company Option) is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":13.89,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1508930,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7650,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each option to purchase shares of Company Common Stock (a Company Option) that was then outstanding but not then vested or exercisable became immediately vested and exercisable in full. At the Effective Time, each Company Option that was then outstanding was automatically cancelled and, if such Company Option had a per share exercise price less than the Merger Consideration, the holder thereof became entitled to receive a cash payment, without interest thereon and subject to any applicable tax withholding, equal to the product obtained by multiplying (i) the total number of shares of Company Common Stock underlying such Company Option by (ii) the excess of the Merger Consideration over the exercise price per share such Company Option."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"(Continued from Footnote 7)  Any Company Option that had an exercise price per share that was equal to or exceeded the Merger Consideration was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option to purchase shares of Company Common Stock (the Company Option) is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":13.45,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":7650},"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1508929,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7650,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each option to purchase shares of Company Common Stock (a Company Option) that was then outstanding but not then vested or exercisable became immediately vested and exercisable in full. At the Effective Time, each Company Option that was then outstanding was automatically cancelled and, if such Company Option had a per share exercise price less than the Merger Consideration, the holder thereof became entitled to receive a cash payment, without interest thereon and subject to any applicable tax withholding, equal to the product obtained by multiplying (i) the total number of shares of Company Common Stock underlying such Company Option by (ii) the excess of the Merger Consideration over the exercise price per share such Company Option."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"(Continued from Footnote 7)  Any Company Option that had an exercise price per share that was equal to or exceeded the Merger Consideration was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option to purchase shares of Company Common Stock (the Company Option) is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.6233,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":7650},"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1508928,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7650,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each option to purchase shares of Company Common Stock (a Company Option) that was then outstanding but not then vested or exercisable became immediately vested and exercisable in full. At the Effective Time, each Company Option that was then outstanding was automatically cancelled and, if such Company Option had a per share exercise price less than the Merger Consideration, the holder thereof became entitled to receive a cash payment, without interest thereon and subject to any applicable tax withholding, equal to the product obtained by multiplying (i) the total number of shares of Company Common Stock underlying such Company Option by (ii) the excess of the Merger Consideration over the exercise price per share such Company Option."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"(Continued from Footnote 7)  Any Company Option that had an exercise price per share that was equal to or exceeded the Merger Consideration was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option to purchase shares of Company Common Stock (the Company Option) is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.7008,"expiration_date":"2029-01-17","underlying":"Common Stock","underlying_shares":7650},"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1508927,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-18","kind":"other","planned":false,"acquired":false,"shares":1735544,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the Merger Agreement), dated April 10, 2024, among Alpine Immune Sciences, Inc., a Delaware corporation (the Company), Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (Parent), and Adams Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (Merger Sub). Pursuant to the Merger Agreement, Merger Sub completed a tender offer for shares of the Companys Common Stock, par value $0.001 per share (Company Common Stock), effective May 18, 2024 (the Offer Closing), and thereafter merged with and into the Company (the Merger, and together with the Offer Closing, the Transactions), effective May 20, 2024 (the Effective Time), with the Company surviving the Merger as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) In connection with the consummation of the Transactions, each share of the Company Common Stock was either (x) purchased at the Offer Closing for $65.00 in cash per share (the Offer Price), without interest thereon and subject to any applicable tax withholding or (y) automatically converted in the Merger at the Effective Time into the right to receive the Offer Price in cash, without interest thereon (the Merger Consideration), subject to any applicable tax withholding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are owned directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Xiangmin Cui is the indirect managing member and ultimate beneficial owner of Decheng Capital Global Healthcare GP, LLC, the general partner of Healthcare.  Dr. Cui disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1508926,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-18","kind":"other","planned":false,"acquired":false,"shares":6582380,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the Merger Agreement), dated April 10, 2024, among Alpine Immune Sciences, Inc., a Delaware corporation (the Company), Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (Parent), and Adams Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (Merger Sub). Pursuant to the Merger Agreement, Merger Sub completed a tender offer for shares of the Companys Common Stock, par value $0.001 per share (Company Common Stock), effective May 18, 2024 (the Offer Closing), and thereafter merged with and into the Company (the Merger, and together with the Offer Closing, the Transactions), effective May 20, 2024 (the Effective Time), with the Company surviving the Merger as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) In connection with the consummation of the Transactions, each share of the Company Common Stock was either (x) purchased at the Offer Closing for $65.00 in cash per share (the Offer Price), without interest thereon and subject to any applicable tax withholding or (y) automatically converted in the Merger at the Effective Time into the right to receive the Offer Price in cash, without interest thereon (the Merger Consideration), subject to any applicable tax withholding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Xiangmin Cui is the manager of Decheng Capital Management III (Cayman), LLC, the general partner of Fund III. Dr. Cui disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1673916,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2024-01-22T18:54:12.000Z","date":"2024-01-18","kind":"other","planned":false,"acquired":false,"shares":1234636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reportable securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Xiangmin Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. GP III disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein. Dr. Cui is a director of the Issuer and files separate Section 16 reports."}],"balance_after":0,"derivative":{"exercise_price":12.74,"exercise_date":"2019-01-18","expiration_date":"2024-01-18","underlying":"Common Stock","underlying_shares":1234636},"source":{"system":"sec-edgar","filing":"0001209191-24-002016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1626199/000120919124002016/doc4.xml","form_type":"4"}},{"id":1673915,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-22T18:54:12.000Z","date":"2024-01-18","kind":"other","planned":false,"acquired":true,"shares":1234636,"price":12.74,"value":15729262.64,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reportable securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Xiangmin Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. GP III disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein. Dr. Cui is a director of the Issuer and files separate Section 16 reports."}],"balance_after":6582380,"source":{"system":"sec-edgar","filing":"0001209191-24-002016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1626199/000120919124002016/doc4.xml","form_type":"4"}},{"id":2150399,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-27T16:46:31.000Z","date":"2022-09-23","kind":"grant","acquired":true,"shares":1360544,"price":7.35,"value":9999998.4,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reportable securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healtchcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Xiangmin Cui is the indirect managing member and ultimate beneficial owner of Healthcare GP. Each of Healthcare, Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Healthcare GP disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein. Dr. Cui is a director of the Issuer and files separate Section 16 reports."}],"balance_after":1360544,"source":{"system":"sec-edgar","filing":"0001209191-22-051370","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1626199/000120919122051370/doc4.xml","form_type":"4"}},{"id":2150398,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-27T16:46:31.000Z","date":"2022-09-23","kind":"grant","acquired":true,"shares":639456,"price":7.35,"value":4700001.6,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reportable securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Xiangmin Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. GP III disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein. Dr. Cui is a director of the Issuer and files separate Section 16 reports."}],"balance_after":5347744,"source":{"system":"sec-edgar","filing":"0001209191-22-051370","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1626199/000120919122051370/doc4.xml","form_type":"4"}},{"id":2555638,"issuer":{"id":87957,"kind":"organization","name":"Cue Health Inc.","symbol":"HLTH"},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"ten_percent_owner":true}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"ten_percent_owner":true}}],"security":"Series C-1 Preferred Stock","published_at":"2021-09-30T21:48:48.000Z","date":"2021-09-28","kind":"exercise","acquired":false,"shares":8192468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 28, 2021, the Series C-1 Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 28, 2021, the Series C-1 Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 28, 2021, the Series C-1 Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (the \"Fund\"). Decheng Capital Management III (Cayman), LLC (the \"GP\") is the general partner of the Fund. Xiangmin Cui is the manager of the GP. Each of the Fund, the GP and Dr. Cui may be deemed to beneficially own the securities held by the Fund. Each of the Fund, the GP and Dr. Cui disclaim beneficial ownership of these securities, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8192468},"source":{"system":"sec-edgar","filing":"0001140361-21-033150","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628945/000114036121033150/form4.xml","form_type":"4"}},{"id":2555637,"issuer":{"id":87957,"kind":"organization","name":"Cue Health Inc.","symbol":"HLTH"},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"ten_percent_owner":true}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2021-09-30T21:48:48.000Z","date":"2021-09-28","kind":"exercise","acquired":true,"shares":8192468,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 28, 2021, the Series C-1 Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (the \"Fund\"). Decheng Capital Management III (Cayman), LLC (the \"GP\") is the general partner of the Fund. Xiangmin Cui is the manager of the GP. Each of the Fund, the GP and Dr. Cui may be deemed to beneficially own the securities held by the Fund. Each of the Fund, the GP and Dr. Cui disclaim beneficial ownership of these securities, except to the extent of their respective pecuniary interests therein."}],"balance_after":8192468,"source":{"system":"sec-edgar","filing":"0001140361-21-033150","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628945/000114036121033150/form4.xml","form_type":"4"}},{"id":2562659,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-09-21T18:39:38.000Z","date":"2021-09-17","kind":"purchase","acquired":true,"shares":1542553,"price":9.4,"value":14499998.2,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reportable securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (the \"Fund\"). Decheng Capital Management III (Cayman), LLC (the \"GP\") is the general partner of the Fund. Xiangmin Cui is the manager of the GP. Each of the Fund, the GP and Dr. Cui may be deemed to beneficially own the securities held by the Fund. Each of the Fund, the GP and Dr. Cui disclaim beneficial ownership of these securities, except to the extent of their respective pecuniary interests therein."}],"balance_after":4708288,"source":{"system":"sec-edgar","filing":"0001626199-21-000118","document":"wf-form4_163226396485220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1626199/000162619921000118/wf-form4_163226396485220.xml","form_type":"4"}}]}